Iran's president accuses the U.S. Congress of meddling in the nuclear deal. The White House will remove Cuba from the terrorism-sponsor list. And Europe files an anti-trust case against Google. A panel of journalists joins Diane for analysis of the week's top international news stories.
Botox is the latest innovation in cosmetic improvements, using a substance derived from lethal bacteria to prevent or get rid of "worry lines" on the forehead. But it’s long been used as a therapeutic agent for treatment of certain neuromuscular disorders. A panel talks about how Botox works and how it’s used today.
For more information about dystonias, call the Dystonia Medical Research Foundation at 1-800-377-DYST (3978). For more information about Diane’s vocal disorder, contact the National Spasmodic Dysphonia Association at 1-800-795-NSDA (6732).
- Dr. Cheryl Burgess medical director of the Center for Dermatology in Washington, DC
- Dr. Cynthia Kleppinger medical officer and clinical reviewer in the Food and Drug Administration's Center for Biologics Evaluation and Research
- Dr. Stephen Reich associate professor of neurology at the University of Maryland School of Medicine, and director of the Maryland Parkinson's Disease and Movement Disorders Center
Most Recent Shows
The 2016 presidential campaign begins in earnest. National protests for a $15 minimum wage heat up. And Boston marks the two-year anniversary of the marathon bombings. A panel of journalists joins Diane for analysis of the week's top national news stories.
New York Times Columnist David Brooks says American culture’s obsession with individual achievement and self-worth has gone too far. In a new book, he argues it is time to rethink what makes a fulfilling life and become more humble, kind and self-sacrificing.
Congress has reached agreement on oversight of the Iran nuclear deal and a Medicare "doc fix," and is working on fast-track trade authority for President Barack Obama. A hundred days into the new Republican-led Congress, we look at what’s been accomplished and what’s to come.